Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (303)
ARTG (234)
Prescription medicine registration (15)

Date

2024 (31)
2023 (161)
2022 (28)
2021 (55)
2020 (48)
2019 (26)
2018 (52)
2017 (35)
2016 (78)
2014 (2)
2013 (9)
2012 (16)
2011 (2)
2010 (9)

Results for "[search-keyword]"

Search

Sponsor content

552 result(s) found, displaying 241 to 250

CIPROFLOXACIN-DRLA ciprofloxacin 750mg (as hydrochloride monohydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 July 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
CIPROFLOXACIN-DRLA ciprofloxacin 500mg (as hydrochloride monohydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 July 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
CIPROFLOXACIN-DRLA ciprofloxacin 250mg (as hydrochloride monohydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 July 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN GENERICHEALTH rosuvastatin (as calcium) 5 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN GENERICHEALTH rosuvastatin (as calcium) 20 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
ROSUVASTATIN GENERICHEALTH rosuvastatin (as calcium) 40 mg film-coated tablets blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
DAPTOMYCIN DR.REDDY'S daptomycin 500 mg powder for injection vial (337791)

15 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DAPTOMYCIN DR.REDDY'S daptomycin 500 mg powder for injection vial.
DAPTOMYCIN DR.REDDY'S daptomycin 350 mg powder for injection vial (337790)

15 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DAPTOMYCIN DR.REDDY'S daptomycin 350 mg powder for injection vial.
DAPTOMYCIN-DRLA daptomycin 500 mg powder for injection vial (337789)

15 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DAPTOMYCIN-DRLA daptomycin 500 mg powder for injection vial.
REDDY'S-DAPTOMYCIN daptomycin 500 mg powder for injection vial (337794)

15 April 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for REDDY'S-DAPTOMYCIN daptomycin 500 mg powder for injection vial.

Pages

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.